miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7
Affiliations: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China, Department of Gynecology and Obstetrics, Tianjin First Central Hospital, Tianjin 300192, P.R. China
- Published online on: April 27, 2020 https://doi.org/10.3892/ijo.2020.5055
- Pages: 264-276
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.